Xiao-Zhou Mou (Xiaozhou Mou)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 13

Top Venues

Biotechnology letters

Contrast media & molecular imaging

Cancer cytopathology

Cancers

Zhejiang University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Zhejiang University Sep 01 2006 - Jun 30 2011

China

PHD :: School of Medicine

Zhejiang Gongshang University Sep 01 2002 - Jun 30 2006

China

BSC :: School of Food Science and Biotechnology

Publications

Dapeng Chen, Jinjun Shao, Tian Zhang, Kang Xu, Chen Liang, Yu Cai, Yuxin Guo, Peng Chen, Xiao-Zhou Mou, Xiaochen Dong
Aromaticity Tuning of Heavy-Atom-Free Photosensitizers for Singlet Fission-Enhanced Immunogenic Photodynamic Oncotherapy. Nano letters (2024)
Shibing Wang, Xue Yang, Ying-Yu Ma, Junjie Wu, Ke-Tao Jin, Ruibo Zhao, Hai Zou, Xiao-Zhou Mou
An engineered self-biomineralized oncolytic adenovirus induces effective antitumor immunity and synergizes with immune checkpoint blockade. Cancer immunology research (2024)
Cheng-Wu Zhang, Jun-Gang Zhang, Xue Yang, Wen-Lin Du, Zi-Lin Yu, Zhen-Ye Lv, Xiao-Zhou Mou
Carbohydrates based stimulus responsive nanocarriers for cancer-targeted chemotherapy: a review of current practices. Expert opinion on drug delivery 19 (6) (2022)
Hai Zou, Jun Zhang, Kan Zhan, Xiao-Zhou Mou, Biao Zhu
A narrative review of new research progress regarding the use of airway stents in benign airway stenosis. Expert review of respiratory medicine 16 (6) (2022)
Ke-Tao Jin, Wen-Lin Du, Yu-Yao Liu, Huan-Rong Lan, Jing-Xing Si, Xiao-Zhou Mou
Oncolytic Virotherapy in Solid Tumors: The Challenges and Achievements. Cancers 13 (4) (2021)
Ke-Tao Jin, Wen-Lin Du, Huan-Rong Lan, Yu-Yao Liu, Chun-Sen Mao, Jin-Lin Du, Xiao-Zhou Mou
Development of humanized mouse with patient-derived xenografts for cancer immunotherapy studies: A comprehensive review. Cancer science 112 (7) (2021)
Pei-Yang Hu, Xiao-Ming Fan, You-Ni Zhang, Shi-Bing Wang, Wei-Jie Wan, Hong-Ying Pan, Xiao-Zhou Mou
The limiting factors of oncolytic virus immunotherapy and the approaches to overcome them. Applied microbiology and biotechnology 104 (19) (2020)
You-Ni Zhang, Shi-Bing Wang, Shu-Shu Song, Pei-Yang Hu, Yu-Cheng Zhou, Yi-Ping Mou, Xiao-Zhou Mou
Recent advances in targeting cancer stem cells using oncolytic viruses. Biotechnology letters 42 (6) (2020)
Ying Wang, Wanyuan Chen, Jiayan Lian, Haibo Zhang, Bo Yu, Minjun Zhang, Fangqiang Wei, Jianhui Wu, Jiaxiang Jiang, Yongshi Jia, Fan Mo, Shirong Zhang, Xiaodong Liang, Xiao-Zhou Mou, Jianming Tang
The lncRNA PVT1 regulates nasopharyngeal carcinoma cell proliferation via activating the KAT2A acetyltransferase and stabilizing HIF-1α. Cell death and differentiation 27 (2) (2019)
Xiao-Yi Chen, Jin-Yang Chen, Xiang-Min Tong, Jian-Guo Mei, Yun-Fang Chen, Xiao-Zhou Mou
Recent advances in the use of microcarriers for cell cultures and their ex vivo and in vivo applications. Biotechnology letters 42 (1) (2019)
Ke-Tao Jin, Huan-Rong Lan, Xiao-Yi Chen, Shi-Bing Wang, Xiao-Jiang Ying, Yan Lin, Xiao-Zhou Mou
Recent advances in carbohydrate-based cancer vaccines. Biotechnology letters 41 (6-7) (2019)
Ke-Tao Jin, Xiao-Yi Chen, Huan-Rong Lan, Shi-Bing Wang, Xiao-Jiang Ying, Siyad Mohamed Abdi, Wei Wang, Zhi-Ming Hu, Xiao-Zhou Mou
Current progress in the clinical use of circulating tumor cells as prognostic biomarkers. Cancer cytopathology 127 (12) (2019)
Ying-Yu Ma, Ke-Tao Jin, Shi-Bing Wang, Hui-Ju Wang, Xiang-Min Tong, Dong-Sheng Huang, Xiao-Zhou Mou
Molecular Imaging of Cancer with Nanoparticle-Based Theranostic Probes. Contrast media & molecular imaging 2017 (2017)

Xiao-Zhou Mou.css-eqlu8i{font-size:small;padding-left:4px;} (Xiaozhou Mou)

Publication Activity (10 Years)

Top Topics

Top Venues

Xiao-Zhou Mou (Xiaozhou Mou)